Colorectal Cancer | ICHOM – International Consortium for Health Outcomes Measurement
Colorectal Cancer

Colorectal cancer

Read the paper on our Colorectal Cancer Standard Set that was published by JAMA Oncology.


european_urology


The ICHOM Standard Set for Colorectal cancer is the result of hard work by a group of leading physicians, measurement experts and patients. It is our recommendation of the outcomes that matter most to persons with Colorectal cancer. We urge all providers around the world to start measuring these outcomes to better understand how to improve the lives of their patients.
CRC

1 Complications will be recorded based on the type of therapy needed or action required to correct the complication as described in the Clavien-Dindo Classification and CTCAE v4.0.
2,3,4 Recommeded to track via the EORTC Quality of Life Questionnaire - Core Questionnaire (EORTC QLQ-C30).
5 Includes bowel functioning, fecal leakage, stool frequency, diarrhea and dietary issues. Recommeded to track via the dietary subscale of the Memorial Sloan-Kettering Cancer Center (MSKCC) Bowel Function. Recommeded to track via the EORTC Quality of Life Questionnaire - Colorectal Cancer Module (EORTC QLQ-CR29).
6 Recommended to track via a single item from the EORTC Quality of Life Questionnaire - Liver Metastases Colorectal Module (EORTC QLQ-LMC21).
7 Recommended to track via the EORTC Quality of Life Questionnaire - Colorectal Cancer Module (EORTC QLQ-CR29).
8 Includes erectile dysfunction and vaginal symptoms. Recommended to track via the EORTC Quality of Life Questionnaire - Colorectal Cancer Module (EORTC QLQ-CR29).
9 Includes physical, emotional and social functioning and mobility and overall well-being. Recommended to track via the EORTC Quality of Life Questionnaire - Core Questionnaire (EORTC QLQ-C30).
10 Includes overall and cause-specific survival.
11 Includes pathologic complete response, margin status and recurrence and progression free survival.
12 Includes place of death and preference for place of death according to the patient.


© 2016 ICHOM. All rights reserved. When using this set of outcomes, or quoting therefrom, in any way, we solely require that you always make a reference to ICHOM as the source so that this organization can continue its work to define more standard outcome sets.


Team that developed this standard


Australia

Donna Bauer* | Bowel Cancer Australia
Craig Lynch | Peter MacCallum Cancer Center
John ZalcBerg | Monash University

Belgium

Eric van Cutsem | Leuven Cancer Institute

Germany

Corinna Langelotz | Universitätsmedizin Berlin-Charité

Malaysia

Muhammad Radzi Abu Hassan | Hospital Sultanah Bahiyah

Netherlands

Rob Tollenaar | Leiden University Medical Center
Cornelis van de Velde | Leiden University Medical Center
Eino van Duyn | Medisch Spectrum Twente

Singapore

Joanne Ngeow | National Cancer Centre Singapore

Spain

Josep Borras | University of Barcelona

Taiwan

Skye Hung-Chung Chen | Koo Foundation Sun Yat-Sen Cancer Center

United Kingdom

Michael Fenn* | AOL community

United States

Ann Berger | University of Nebraska Medical Center
Giles Boland | Harvard Medical School
Robert Cima | Robert Cima
Sam Finlayson | University of Utah
John Lloyd* | Colon Cancer Alliance
Harvey Mamon | Dana Farber Cancer Institute
Pamela McAllister* | Fight Colorectal Cancer
Bruce Minsky | MD Anderson Cancer Center
Kim Ryan* | Cancer Support Community
Veena Shankaran | University of Washington Medical Center
Melissa Upton | University of Washington Medical Center
Jessica Zerillo | Beth Israel Deaconess Medical Center

*Patient representative

Receive Updates


Reference Guide

A complete overview of the ICHOM Standard Set, including definitions for each measure and selected PROM instruments, time points for collection, and associated risk factors is available here:

dl_ref_guide_pd_3

Version 1.1.0: September 13th, 2017

775 KB

Get the Flyer

1.9 MB

Get the Database

40 KB

How to measure?

Interested in measuring the ICHOM Standard Set? Learn how to measure.